JP2019509344A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509344A5
JP2019509344A5 JP2019500035A JP2019500035A JP2019509344A5 JP 2019509344 A5 JP2019509344 A5 JP 2019509344A5 JP 2019500035 A JP2019500035 A JP 2019500035A JP 2019500035 A JP2019500035 A JP 2019500035A JP 2019509344 A5 JP2019509344 A5 JP 2019509344A5
Authority
JP
Japan
Prior art keywords
fatty acids
omega
lipid
triglyceride
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019500035A
Other languages
English (en)
Japanese (ja)
Other versions
JP6738477B2 (ja
JP2019509344A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/000548 external-priority patent/WO2017158439A1/en
Publication of JP2019509344A publication Critical patent/JP2019509344A/ja
Publication of JP2019509344A5 publication Critical patent/JP2019509344A5/ja
Application granted granted Critical
Publication of JP6738477B2 publication Critical patent/JP6738477B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019500035A 2016-03-16 2017-03-15 ω−3脂肪酸誘導体を含む粉末及び錠剤、ならびにその製造方法 Active JP6738477B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662309013P 2016-03-16 2016-03-16
US62/309,013 2016-03-16
PCT/IB2017/000548 WO2017158439A1 (en) 2016-03-16 2017-03-15 Powders and tablets comprising omega-3 fatty acid derivatives and methods for their production

Publications (3)

Publication Number Publication Date
JP2019509344A JP2019509344A (ja) 2019-04-04
JP2019509344A5 true JP2019509344A5 (enExample) 2020-04-23
JP6738477B2 JP6738477B2 (ja) 2020-08-12

Family

ID=58994957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019500035A Active JP6738477B2 (ja) 2016-03-16 2017-03-15 ω−3脂肪酸誘導体を含む粉末及び錠剤、ならびにその製造方法

Country Status (11)

Country Link
US (1) US20190364946A1 (enExample)
EP (1) EP3429377B1 (enExample)
JP (1) JP6738477B2 (enExample)
KR (1) KR102263900B1 (enExample)
CN (1) CN109068707B (enExample)
AU (1) AU2017232554B2 (enExample)
BR (1) BR112018068855A2 (enExample)
CA (1) CA3017825C (enExample)
CL (1) CL2018002656A1 (enExample)
ES (1) ES2836729T3 (enExample)
WO (1) WO2017158439A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
AU2021276611A1 (en) 2020-05-18 2022-12-15 Orexo Ab New pharmaceutical composition for drug delivery
JP2024541470A (ja) 2021-11-25 2024-11-08 オレクソ・アクチエボラゲット アドレナリンを含む医薬組成物
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110009A1 (de) * 1981-03-11 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue benzofuran-derivate, ihre herstellung und verwendung
CN1140332C (zh) * 2001-10-24 2004-03-03 中国科学院新疆化学研究所 共轭亚油酸或共轭亚油酸酯的微胶囊
CN1152739C (zh) * 2001-10-26 2004-06-09 中国科学院新疆理化技术研究所 共轭亚油酸及其衍生物的环糊精包结的微胶囊
CN1295970C (zh) * 2005-07-08 2007-01-24 浙江大学 山茶油微胶囊的制备方法
CN101227826B (zh) * 2005-07-22 2012-09-05 荷兰联合利华有限公司 饮料前体及其制备方法
CN101316827A (zh) * 2005-09-30 2008-12-03 詹森药业有限公司 作为rxr激动剂用于治疗异常脂肪血症、高胆固醇血症和糖尿病的杂环酰胺衍生物
WO2008036353A2 (en) * 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
JP4463875B2 (ja) * 2007-03-29 2010-05-19 第一三共株式会社 医薬組成物
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
AU2010222648B2 (en) * 2009-03-09 2016-07-07 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
CN101692853B (zh) * 2009-10-12 2012-05-30 华南农业大学 一种可食性粉末茶油及其制备方法
WO2011048493A1 (en) * 2009-10-23 2011-04-28 Pronova Biopharma Norge As Coated capsules and tablets of a fatty acid oil mixture
EP2613766A4 (en) * 2010-09-08 2014-04-09 Pronova Biopharma Norge As COMPOSITIONS COMPRISING AN OIL MIXTURE CONSISTING OF FATTY ACIDS COMPRISING EPA AND DHA AS FREE ACID, SURFACTANT AND STATIN
ES2685291T3 (es) * 2010-12-21 2018-10-08 Omegatri As Antioxidantes en polvo de aceite de pescado y comprimidos
AU2013240427B2 (en) * 2012-03-30 2017-08-03 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions
EP2844234B1 (de) * 2012-04-27 2020-01-08 Merck Patent GmbH Tabletten mit überzug und deren herstellung
WO2015100406A1 (en) * 2013-12-26 2015-07-02 Clarus Therapeutics, Inc. Use of oral pharmaceutical products combining testosterone esters with hypolipidemic agents
CN104920639B (zh) * 2015-07-03 2018-08-21 山东省农业科学院农产品研究所 一种牡丹籽油微胶囊的制备方法
CN106035752A (zh) * 2016-06-08 2016-10-26 华南理工大学 一种富含植物甾醇的多不饱和油脂粉末及其制备方法

Similar Documents

Publication Publication Date Title
JP2019509344A5 (enExample)
JP2013508296A5 (enExample)
HRP20200068T1 (hr) Etilni ester ikozapentaenske kiseline, namijenjen liječenju hipertrigliceridemije
JP2015520235A5 (enExample)
JP2018184458A5 (enExample)
CN101816420A (zh) 一种微乳化多不饱和脂肪酸产品及制备方法
EP3062785A1 (en) Enteric soft capsules comprising polyunsaturated fatty acids
CA2781525A1 (en) Coated capsules and tablets of a fatty acid oil mixture
EP2046305A2 (en) Pharmaceutical composition for the oral administration of omega polyenoic fatty acids
JP2011519349A5 (enExample)
WO2019008101A1 (en) ENTERICALLY COATED SOLID DOSAGE FORM COMPRISING AMINO ACIDS SALTS OF OMEGA-3 FATTY ACIDS
US20210121429A1 (en) Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
CA2625554A1 (en) Enteric soft capsule comprising valproic acid
FI3664628T3 (fi) Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia
SI2470165T1 (en) Composition of film for coating from solid powdery compounds
RU2016115985A (ru) Лактоферрин для лечения ibd, вызванного бактериальной инвазией
CA3025425A1 (en) Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
JP4874651B2 (ja) 軟カプセル剤
JP2017516811A5 (enExample)
JP2017501972A5 (enExample)
WO2008088808A1 (en) Treatment with non-steroidal anti-inflammatory drugs and omega-3 fatty acids, and a combination product thereof
JP5847475B2 (ja) 油脂含有組成物、及びそれを含む経口製剤
US9314435B2 (en) Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
RU2018146790A (ru) Дисперсии органических пероксидов
RU2015132458A (ru) Пленочное покрытие препаративных форм, содержащих биологически активные вещества, суспензия для его формирования и способ его нанесения